Biomarkers for Immuno-Oncology

Disease immunotherapy is the utilization of the safe framework to treat tumor. Immunotherapies can be ordered as dynamic, uninvolved or half and half. These methodologies abuse the way that growth cells frequently have atoms on their surface that can be distinguished by the resistant framework, known as tumor-related antigens, they are regularly proteins or different macromolecules (e.g. sugars).

Dynamic immunotherapy guides the resistant framework to assault tumor cells by focusing on TAAs. Latent immunotherapies upgrade existing against tumor reactions and incorporate the utilization of monoclonal antibodies, lymphocytes and cytokines.

  • Personalized Immunotherapy
  • Companion Diagnostics For Immunotherapy
  • Biomarkers to guide Immunotherapy
  • Clinical Trials for Cancer Immunotherapy

Related Conference of Biomarkers for Immuno-Oncology

October 18-20, 2017

10th World Congress on Biomarkers & Clinical Research

Baltimore, USA
November 13-15,2017

17th World Fitness Expo

(10 Plenary Forums - 1Event) Atlanta, USA
December 07-08, 2017

29th World Psychiatrists Meet

Dubai, UAE
March 22-24, 2018

Annual Physicians Meeting 2018

Dubai, UAE
April 16-17, 2018

World Congress on Gynecology and Obstetrics

April 16-17, 2018
April 23-24, 2018

International Conference on Internal Medicine

Dubai, UAE
June 21-22, 2018

3rd International Conference on Anesthesia

Dublin, Ireland
September 24-25, 2018

9th International Conference on Clinical & Medical Case Reports

| Amsterdam, Netherlands
October 15-16, 2018

Annual congress on Research and Innovations in Medicine

Seoul, South Korea
November 27-28, 2018

World Summit on Psychiatry and Mental Health Nursing

Los Angeles, USA

Biomarkers for Immuno-Oncology Conference Speakers

Recommended Sessions

Related Journals

Are you interested in